CD274 and head and neck squamous cell carcinoma: Standardized conventional treatment modalities are being currently applied for both HPV(+) HNSCC and HPV(−) HNSCC, which include surgery, radiation, chemotherapy (or combination), cetuximab (for all HNSCC), and two newly approved PD-L1 inhibitors (pembrolizumab and nivolumab).